%A CHU Hui-Li, LIANG Xiu-Ju, BI Jing-Wang %T EGFR mutation in malignant pleural effusion of non-small cell lung cancer %0 Journal Article %D 2013 %J Journal of International Oncology %R %P 595-597 %V 40 %N 8 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9150.shtml} %8 2013-08-08 %X EGFR testing has become the consensus before EGFR-TKI treatment in non-small cell lung cancer patients. Malignant pleural effusion is the common clinical manifestation in NSCLC patients, and EGFR testing by using different methods in pleural effusion cells and free nucleic acids has good prospect for predicting the efficacy of EGFR-TKI.